share

4(3H)-Quinazolinone, 3-(5-(4-Morpholinylmethyl)-1,3,4-Thiadiazol-2-Yl) -2-Phenyl- CAS NO 74796-89-7


Unit Price:

CAS No.:74796-89-7

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

4(3H)-Quinazolinone, 3-(5-(4-Morpholinylmethyl)-1,3,4-Thiadiazol-2-Yl) -2-Phenyl- is a sophisticated heterocyclic organic compound featuring a quinazolinone core fused with a substituted 1,3,4-thiadiazole moiety. This unique molecular architecture makes it a valuable advanced pharmaceutical intermediate and a key scaffold for medicinal chemistry research. It is primarily sought after by R&D teams in the pharmaceutical and biotechnology sectors for the development of novel therapeutic agents.

Application

  • Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of potential drug candidates targeting various diseases.
  • Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
  • Kinase Inhibitor Development: The quinazolinone-thiadiazole hybrid structure is of significant interest for designing novel kinase inhibitors.
  • Anticancer Agent Research: Investigated as a precursor for compounds with potential antiproliferative and antitumor activities.
  • Chemical Biology Probes: Utilized in the development of molecular probes to study biological pathways and protein functions.
  • Organic Synthesis Reference Standard: Acts as a high-purity reference material for analytical method development and validation.

Basic Information

Product Name 4(3H)-Quinazolinone, 3-(5-(4-Morpholinylmethyl)-1,3,4-Thiadiazol-2-Yl) -2-Phenyl-
CAS No. 74796-89-7
Molecular Formula C21H19N5O2S
Molecular Weight 405.47 g/mol
Synonyms 2-Phenyl-3-[5-(4-morpholinylmethyl)-1,3,4-thiadiazol-2-yl]-4(3H)-quinazolinone; 3-(5-(Morpholin-4-ylmethyl)-1,3,4-thiadiazol-2-yl)-2-phenylquinazolin-4(3H)-one; 74796-89-7; Quinazolinone-thiadiazole derivative; 4(3H)-Quinazolinone, 3-(5-(4-morpholinylmethyl)-1,3,4-thiadiazol-2-yl)-2-phenyl-
EINECS Contact for details

Quality Control

Our high-purity pharmaceutical intermediate is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided with each shipment. We support our clients' regulatory needs with full traceability and documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to maintain optimal stability.

Specification

Item Specification
Appearance Off-white to light yellow crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Conforms to reference standard
Purity (HPLC) ≥ 98.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.